EVI’s financial reporting is now streamlined and more efficient.

The first annual meeting of the EU-funded project ZIKAVAX took place on 7 December 2017 at CEA, Fontenay-aux-Roses, France.

EDCTP funded MVVC2 study published today in Frontiers in Immunology.

Funding has been awarded by the GHIT Fund to complete preclinical development and for preparing Phase I Clinical Trial.

EDUFLUVAC partners met for the final project meeting on 09-10 October in Brussels, Belgium.

EU Research Framework Programme activities in the field of Poverty-Related and Neglected Diseases.

MEB is a regulatory agency and an independent administrative body residing under the Government of the Netherlands.

During the first year of the VAC2VAC project ample of process has been made.

The European Commission (EC), in the context of the Horizon 2020 Framework Programme, commits significant funding to TRANSVAC2, a...

In a news piece published by Nature, findings are summarised that highlight the important role vaccines could play as a strategy to...

Science for Preparedness and Response in the Mediterranean Region.

Four years of European research on the development of universal influenza vaccines: what have we learnt, and how can we move forward?

The workshop will be held in Brussels, Belgium on 12-14 June 2017.

World Malaria Day is a chance to shine a spotlight on the global effort to control malaria.

The meeting report from the EDUFLUVAC workshop is now available.

“Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants”

EVI extends a warm welcome to María del Mar Castro.

EURIPRED facilitates and supports translational research for poverty related diseases, such as HIV, TB, malaria and hepatitis.

A new paper related to the MVVC project has recently been published in the PLoS One journal.